Drug Trial Radar · NCT02972359
Safety of Intravenous Neridronic Acid in CRPS
Last checked: Nov 19, 2026Latest source record: Nov 21, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
580
Actual
Start
Dec 20, 2016
Primary completion
Jan 9, 2019
Study completion Jan 9, 2019
Sponsor
- Lead sponsor
- Grünenthal GmbHIndustry
- Sponsor type
- Industry
- First posted
- Nov 23, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this trial was to investigate the safety of intravenous neridronic acid in patients with complex regional pain syndrome (CRPS). The trial was divided into 3 periods: a 60-day enrollment period, a treatment period consisting of 4 infusions over 10 days, and a follow-up period of approximately 50 weeks (with visits at Week 2, Week 6, Week 12, Week 26, Week 39, and Week 52).
Conditions
- Complex Regional Pain Syndrome
Interventions
Neridronic acidDrug
Neridronic acid administered as intravenous infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Occurrence of Any Treatment Emergent Adverse Event (TEAE)Time frame: Day 1 to Week 52
Locations
46 sites in 2 countries. Site status is shown where the registry gives one.
US017: Cactus Clinical Research, Inc.
Phoenix, Arizona
US028: Quality of Life Medical and Research Centers LLC
Tucson, Arizona
US045: Woodland International Research Group
Little Rock, Arkansas
US044: Woodland Research Northwest
Rogers, Arkansas
US012: Orange County Research Institute
Anaheim, California
US022: Core Healthcare Group
Cerritos, California
US033: Alliance Research Centers
Laguna Hills, California
US027: The Helm Center for Pain Management
Laguna Woods, California
US003: Samaritan Center for Medical Research
Los Gatos, California
US010: Catalina Research Institute, LLC
Montclair, California
US014: Northern California Research
Sacramento, California
US034: Mountain View Clinical Research, Inc.
Denver, Colorado
US032: South Lake Pain Institute
Clermont, Florida
US001: Sunrise Research Institute, Inc
Miami, Florida
US046: AMPM Research Clinic
Miami, Florida
US035: Compass Research
Orlando, Florida
US031: Gold Coast Research, LLC
Plantation, Florida
US011: Clinical Research of West Florida, Inc.
Tampa, Florida
US040: Palm Beach Research Center
West Palm Beach, Florida
US026: Better Health Clinical Research Inc.
Newnan, Georgia
US004: Northwestern University - Feinberg School of Medicine - Rehabilitation Institute of Chicago (RIC)
Chicago, Illinois
US036: University Anesthesiologists, S.C.
Chicago, Illinois
US029: Great Lakes Clinical Trials LLC
Chicago, Illinois
US005: International Clinical Research Institute
Overland Park, Kansas
US037: St. Louis Clinical Trials, LC
St Louis, Missouri
US051: Creighton University, Osteoporosis Research Center
Omaha, Nebraska
US002: Princeton Medical Institute
Princeton, New Jersey
US049: Premier Pain Centers, LLC
Shrewsbury, New Jersey
US048: Albany Medical College
Albany, New York
US043: Translational Pain Research, University of Rochester
Rochester, New York
US009: The Center for Clinical Research, LLC
Winston-Salem, North Carolina
US016: North Star Medical Research, LLC
Middleburg Heights, Ohio
US007: Medical Research International
Oklahoma City, Oklahoma
US006: Abington Neurological Associates, LTD.
Willow Grove, Pennsylvania
US020: Clinical Trials of South Carolina
Charleston, South Carolina
US038: Vanderbilt University Medical Center
Nashville, Tennessee
US019: Austin Center for Clinical Research
Austin, Texas
US008: Pioneer Research Solutions
Houston, Texas
US023: Axios Research, LLC
Salt Lake City, Utah
US018: Washington Center for Pain Management
Bellevue, Washington
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.